HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Epigallocatechin gallate (EGCG) inhibits the sulfation of 1-naphthol in a human colon carcinoma cell line, Caco-2.

Abstract
We have previously reported that epigallocatechin gallate (EGCG) strongly inhibits the in vitro phenol sulfotransferase (P-ST) activity of a human colon carcinoma cell line, Caco-2. In the present study, we examined the ability of EGCG to inhibit the sulfation of 1-naphthol in intact Caco-2 cells. Sulfation of 1-naphthol was detected in Caco-2 cells after 2 h of incubation, and was observed to continue for 24 h, resulting in an accumulation of sulfated 1-naphthol. Sulfation was strongly inhibited by the addition of EGCG to the culture medium. The IC50 of EGCG was calculated to be 20 microM; this value is similar to that obtained from in vitro assays (14 microM) [Ref. Tamura et al., Biol. Pharm. Bull., 23, 695, (2000)]. These results indicate that catechins are capable of inhibiting P-ST activity in intact cells as well as in vitro. We believe that the inhibitory activity of catechins might be the mechanism by which catechins (and green tea) exert anti-carcinogenic activity against procarcinogenic compounds that require P-ST activation in vivo.
AuthorsT Isozaki, H Tamura
JournalBiological & pharmaceutical bulletin (Biol Pharm Bull) Vol. 24 Issue 9 Pg. 1076-8 (Sep 2001) ISSN: 0918-6158 [Print] Japan
PMID11558573 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Naphthols
  • Sulfates
  • 1-naphthol
  • Catechin
  • epigallocatechin gallate
  • Arylsulfotransferase
Topics
  • Antineoplastic Agents (pharmacology)
  • Arylsulfotransferase (antagonists & inhibitors)
  • Caco-2 Cells
  • Catechin (analogs & derivatives, pharmacology)
  • Chromatography, High Pressure Liquid
  • Depression, Chemical
  • Enzyme Inhibitors (pharmacology)
  • Humans
  • Naphthols (metabolism)
  • Sulfates (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: